Johnson & Johnson Innovation focuses on accelerating all stages of innovation worldwide, forming collaborations between entrepreneurs and the Johnson & Johnson Family of Companies’ global healthcare businesses. Michael Hübner, Early Innovation Partnering Lead and member of the Swiss Johnson & Johnson Leadership Team discusses how they support breakthrough early innovation through collaboration and strategic partnerships; JLABS, a global network of life science incubators; and JJDC, their own strategic venture capital arm.
Our venture capital arm has a strategic focus which means that our main interest is not the mere financial return on investment but rather helping companies be successful. Therefore, our investment window is perhaps longer than that of Venture Capital firms that are mainly looking for a more near term Return on Investment
